Longitudinal Study for Eosinophilic Granulomatosis With Polyangiitis

Part of paid clinical trials in San Diego, California.

Sponsor
University of Pennsylvania
Study ID
NCT00315380
Status
Recruiting
Apply to this trial

Conditions

  • Churg-Strauss Syndrome
  • Eosinophilic Granulomatosis With Polyangiitis

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Study Details

Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare immune system disorder that causes asthma, an excessive number of eosinophils (a type of white blood cell) in the blood, and the inflammation of blood vessels, or vasculitis. In order to properly treat EGPA, it is critical that the level of disease activity can be determined over the course of the disease. The purpose of this study is to determine new biological markers, or biomarkers, that may be used to assess the severity of this disease in people with EGPA.

Key Dates

Start date
Apr 30, 2006
Status verified
Jan 2026
Primary completion
Dec 31, 2028
Completion
Dec 31, 2028

Study Design

Enrollment
700 participants (estimated)

Primary Outcome Measure

Discover biomarkers in EGPA capable of measuring disease activity and response to treatment [ Time Frame: Study completion ]

Locations (8)

FacilityCityStateZIPSite coordinators
University of California San DiegoSan DiegoCalifornia92122-
National Jewish HealthDenverColorado80206-
Brigham and Women's HospitalBostonMassachusetts02215-
Mayo ClinicRochesterMinnesota55905-
Cleveland Clinic FoundationClevelandOhio44195-
University of PennsylvaniaPhiladelphiaPennsylvania19104-
University of PittsburghPittsburghPennsylvania15260-
University of UtahSalt Lake CityUtah84112-

Find similar trials in San Diego, CA

By research site
University of California San Diego· San Diego, CANational Jewish Health· Denver, COBrigham and Women's Hospital· Boston, MAMayo Clinic· Rochester, MNCleveland Clinic Foundation· Cleveland, OHUniversity of Pennsylvania· Philadelphia, PA

Related Studies